Carboplatin in Patients With Progressive Gliomas [clinicaltrials:NCT00002749]
Carboplatin in Patients With Progressive Gliomas [clinicaltrials:NCT00002749]
Bio2RDF identifier
NCT00002749
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002749
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... ith
progressive glioma.
brief title [clinicaltrials_vocabulary:brief-title]
Carboplatin in Patients With Progressive Gliomas
completion date [clinicaltrials_vocabulary:completion-date]
2000-03-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Assess t ...... onse in the first 9 patients.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
adult anaplastic astrocytoma
adult brain stem glioma
adult oligodendroglioma
childhood low-grade cerebral astrocytoma
childhood oligodendroglioma
recurrent adult brain tumor
recurrent childhood brain stem glioma
recurrent childhood cerebellar astrocytoma
recurrent childhood cerebral astrocytoma
recurrent childhood visual pathway glioma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2009-10-12T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002749
official title [clinicaltrials_vocabulary:official-title]
PHASE II STUDY OF CARBOPLATIN ...... PROGRESSIVE LOW GRADE GLIOMAS
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000064682
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
DUMC-0157-00-1R7
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1993-02-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2009-10-01T00:00:00Z
identifier
clinicaltrials:NCT00002749
title
Carboplatin in Patients With Progressive Gliomas
@en
type
label
Carboplatin in Patients With Progressive Gliomas [clinicaltrials:NCT00002749]
@en